Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mRNA-Heartland Virus vaccine
- Development stage
- Preclinical
- Lead developer
- Vernagen
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
mRNA-Heartland Virus vaccine is an investigational mRNA-based vaccine candidate being developed by Vernagen for the prevention of Heartland Virus (HRTV) infection. The vaccine utilizes mRNA technology to encode specific Heartland virus antigens, which, upon administration, are expressed by the host's cells to trigger a protective immune response. Currently in the preclinical stage, the vaccine's efficacy is being evaluated in collaboration with the Centers for Disease Control and Prevention (CDC) in the United States. This candidate is part of Vernagen's broader mRNA vaccine pipeline targeting emerging pathogens.
- Other names
- mRNA-Heartland Virus vaccineVernagen mRNA Heartland vaccine
02
Targets
HRTV (Heartland virus)
Beyond the preview
Go deeper on mRNA-Heartland Virus vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mRNA-Heartland Virus vaccine.